BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26911891)

  • 1. The effect of oral isotretinoin on visual contrast sensitivity and amount of lacrimation in patients with acne vulgaris.
    Polat M; Kükner Ş
    Cutan Ocul Toxicol; 2017 Mar; 36(1):35-38. PubMed ID: 26911891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
    Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
    Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
    Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
    Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of hematuria in acne vulgaris patients during isotretinoin treatment.
    Yesilkaya B; Alli N; Artuz RF; Ulu E; Kartal D; Cinar SL
    Cutan Ocul Toxicol; 2017 Mar; 36(1):74-76. PubMed ID: 26938860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral isotretinoin on serum folic acid levels.
    Javanbakht AM; Pour HM; Tarrahic MJ
    J Drugs Dermatol; 2012 Sep; 11(9):e23-4. PubMed ID: 23135667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eruptive milia during isotretinoin therapy.
    Farmer W; Cheng K; Marathe K
    Pediatr Dermatol; 2017 Nov; 34(6):728-729. PubMed ID: 28940619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of systemic isotretinoin on female fertility.
    Cinar SL; Kartal D; Aksoy H; Cinar E; Aydin T; Öz L; İmamoğlu H; Ferahbas A; Borlu M
    Cutan Ocul Toxicol; 2017 Jun; 36(2):132-134. PubMed ID: 27292185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of isotretinoin on the inflammatory markers and the platelet counts in patients with acne vulgaris.
    Seçkin HY; Baş Y; Takçı Z; Kalkan G
    Cutan Ocul Toxicol; 2016; 35(2):89-91. PubMed ID: 25853176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotretinoin: update on controversial issues.
    Prevost N; English JC
    J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
    Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T
    Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral isotretinoin therapy of acne patients decreases serum paraoxonase-1 activity through increasing oxidative stress.
    Ozkol HU; Ozkol H; Karadag AS; Bilgili SG; Tuluce Y; Calka O
    Drug Chem Toxicol; 2015 Jan; 38(1):63-6. PubMed ID: 24697846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome of acne vulgaris with oral isotretinoin.
    Bener A; Lestringant GG; Ehlayel MS; Saarinen K; Takiddin AH
    J Coll Physicians Surg Pak; 2009 Jan; 19(1):49-51. PubMed ID: 19149981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myths of isotretinoin therapy in patients with acne: a personal opinion.
    Alcalay J
    J Drugs Dermatol; 2004; 3(2):179-82. PubMed ID: 15098974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced central corneal thickness in patients with isotretinoin treatment.
    Yuksel N; Ozer MD; Akcay E; Ozen U; Uzun S
    Cutan Ocul Toxicol; 2015; 34(4):318-21. PubMed ID: 25597375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of isotretinoin: A large, retrospective review.
    Brzezinski P; Borowska K; Chiriac A; Smigielski J
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28295859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isotretinoin and depressive symptoms in patiens with severe and recurrent acne].
    Rubio-García L; Pulido-Díaz N; Jímenez-López JL
    Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 1():S54-9. PubMed ID: 26020665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.